The North America Renal Denervation Market would witness Market growth of 34.6% CAGR during the forecast period (2022-2028).
Renal denervation (RDN) using a catheter has been shown in clinical trials to lower blood pressure and improve blood pressure control in people with resistant hypertension. The procedure's blood pressure-lowering effect may extend for up to 36 months. Despite the fact that RDN is a promising and growing method, additional evidence from clinical studies is needed to establish its long-term safety and efficacy when compared to the best available pharmaceutical treatment. It would also be critical to recognize the clinical characteristics of individuals who would gain the most from RDN, and the clinical characteristics of non-responders.
Because of changes in lifestyle that contribute to resistant hypertension as well as an increase in the existence of hypertension, the renal denervation industry has grown in size. Additionally, technical improvements have moved the renal denervation Market forward, resulting in the development of various new technologies for renal denervation systems, like micro-infusion. Moreover, the prevalence of hypertension has increased dramatically in recent years, causing blood pressure to fluctuate throughout the day, but if it stays high for an extended period of time, it can damage the patient's heart and cause health complications.
Hypertension increases the risk of heart disease and stroke, both of which are significant causes of death across the region. According to the Center for Disease Control and Prevention, hypertension was a primary or contributing reason to over half a million fatalities in the United States in 2019. In the United States, nearly half of people have hypertension, which is defined as systolic blood pressure higher than 130 mmHg or diastolic blood pressure higher than 80 mmHg, or are taking hypertension medication. Only around one-quarter of persons with hypertension have their condition under control.
Blood pressure of 140/90 mmHg or greater is found in nearly half of adults with uncontrolled hypertension. This comprises 37 million adults in the United States. Approximately 34 million people who have been advised to take medicine may require a prescription and start taking it.
The US Market dominated the North America Renal Denervation Market by Country in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $370.8 million by 2028. The Canada Market is anticipated to grow at a CAGR of 37.7% during (2022 - 2028). Additionally, The Mexico Market would display a CAGR of 36.5% during (2022 - 2028).
Based on Technology, the Market is segmented into Radiofrequency, Ultrasound, and Micro-Infusion. Based on End User, the Market is segmented into Hospitals, Specialty Clinics, and Others. Based on Product Type, the Market is segmented into Symplicity, Enlightn, Vessix, Paradise, Iberis, and Others. Based on countries, the Market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Renal Denervation Market is Estimated to reach $1.4 Billion by 2028, at a CAGR of 36.4%
The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Ablative Solutions, Inc., Mercator MedSystems, Inc., ReCor Medical, Inc., Renal Dynamics Limited, Johnson & Johnson, and Terumo Corporation.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Radiofrequency
- Ultrasound
- Micro-Infusion
By End User
- Hospitals
- Specialty Clinics
- Others
By Product Type
- Symplicity
- Enlightn
- Vessix
- Paradise
- Iberis
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic PLC
- Ablative Solutions, Inc.
- Mercator MedSystems, Inc.
- ReCor Medical, Inc.
- Renal Dynamics Limited
- Johnson & Johnson
- Terumo Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Renal Denervation Market, by Technology
1.4.2 North America Renal Denervation Market, by End User
1.4.3 North America Renal Denervation Market, by Product Type
1.4.4 North America Renal Denervation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Renal Denervation Market by Technology
3.1 North America Radiofrequency Market by Country
3.2 North America Ultrasound Market by Country
3.3 North America Micro-Infusion Market by Country
Chapter 4. North America Renal Denervation Market by End User
4.1 North America Hospitals Market by Country
4.2 North America Specialty Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Renal Denervation Market by Product Type
5.1 North America Symplicity Market by Country
5.2 North America Enlightn Market by Country
5.3 North America Vessix Market by Country
5.4 North America Paradise Market by Country
5.5 North America Iberis Market by Country
5.6 North America Others Market by Country
Chapter 6. North America Renal Denervation Market by Country
6.1 US Renal Denervation Market
6.1.1 US Renal Denervation Market by Technology
6.1.2 US Renal Denervation Market by End User
6.1.3 US Renal Denervation Market by Product Type
6.2 Canada Renal Denervation Market
6.2.1 Canada Renal Denervation Market by Technology
6.2.2 Canada Renal Denervation Market by End User
6.2.3 Canada Renal Denervation Market by Product Type
6.3 Mexico Renal Denervation Market
6.3.1 Mexico Renal Denervation Market by Technology
6.3.2 Mexico Renal Denervation Market by End User
6.3.3 Mexico Renal Denervation Market by Product Type
6.4 Rest of North America Renal Denervation Market
6.4.1 Rest of North America Renal Denervation Market by Technology
6.4.2 Rest of North America Renal Denervation Market by End User
6.4.3 Rest of North America Renal Denervation Market by Product Type
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 Ablative Solutions, Inc.
7.4.1 Company Overview
7.5 Mercator MedSystems, Inc.
7.5.1 Company Overview
7.6 ReCor Medical, Inc (Otsuka Holdings Co., Ltd.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Product Launches and Product Expansions:
7.7 Renal Dynamics Limited
7.7.1 Company Overview
7.8 Johnson & Johnson
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental &Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations and Agreements:
7.9 Terumo Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Acquisition and Mergers:
TABLE 1 North America Renal Denervation Market, 2018 - 2021, USD Thousands
TABLE 2 North America Renal Denervation Market, 2022 - 2028, USD Thousands
TABLE 3 North America Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
TABLE 4 North America Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
TABLE 5 North America Radiofrequency Market by Country, 2018 - 2021, USD Thousands
TABLE 6 North America Radiofrequency Market by Country, 2022 - 2028, USD Thousands
TABLE 7 North America Ultrasound Market by Country, 2018 - 2021, USD Thousands
TABLE 8 North America Ultrasound Market by Country, 2022 - 2028, USD Thousands
TABLE 9 North America Micro-Infusion Market by Country, 2018 - 2021, USD Thousands
TABLE 10 North America Micro-Infusion Market by Country, 2022 - 2028, USD Thousands
TABLE 11 North America Renal Denervation Market by End User, 2018 - 2021, USD Thousands
TABLE 12 North America Renal Denervation Market by End User, 2022 - 2028, USD Thousands
TABLE 13 North America Hospitals Market by Country, 2018 - 2021, USD Thousands
TABLE 14 North America Hospitals Market by Country, 2022 - 2028, USD Thousands
TABLE 15 North America Specialty Clinics Market by Country, 2018 - 2021, USD Thousands
TABLE 16 North America Specialty Clinics Market by Country, 2022 - 2028, USD Thousands
TABLE 17 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 18 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 19 North America Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
TABLE 20 North America Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
TABLE 21 North America Symplicity Market by Country, 2018 - 2021, USD Thousands
TABLE 22 North America Symplicity Market by Country, 2022 - 2028, USD Thousands
TABLE 23 North America Enlightn Market by Country, 2018 - 2021, USD Thousands
TABLE 24 North America Enlightn Market by Country, 2022 - 2028, USD Thousands
TABLE 25 North America Vessix Market by Country, 2018 - 2021, USD Thousands
TABLE 26 North America Vessix Market by Country, 2022 - 2028, USD Thousands
TABLE 27 North America Paradise Market by Country, 2018 - 2021, USD Thousands
TABLE 28 North America Paradise Market by Country, 2022 - 2028, USD Thousands
TABLE 29 North America Iberis Market by Country, 2018 - 2021, USD Thousands
TABLE 30 North America Iberis Market by Country, 2022 - 2028, USD Thousands
TABLE 31 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 32 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 33 North America Renal Denervation Market by Country, 2018 - 2021, USD Thousands
TABLE 34 North America Renal Denervation Market by Country, 2022 - 2028, USD Thousands
TABLE 35 US Renal Denervation Market, 2018 - 2021, USD Thousands
TABLE 36 US Renal Denervation Market, 2022 - 2028, USD Thousands
TABLE 37 US Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
TABLE 38 US Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
TABLE 39 US Renal Denervation Market by End User, 2018 - 2021, USD Thousands
TABLE 40 US Renal Denervation Market by End User, 2022 - 2028, USD Thousands
TABLE 41 US Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
TABLE 42 US Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
TABLE 43 Canada Renal Denervation Market, 2018 - 2021, USD Thousands
TABLE 44 Canada Renal Denervation Market, 2022 - 2028, USD Thousands
TABLE 45 Canada Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
TABLE 46 Canada Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
TABLE 47 Canada Renal Denervation Market by End User, 2018 - 2021, USD Thousands
TABLE 48 Canada Renal Denervation Market by End User, 2022 - 2028, USD Thousands
TABLE 49 Canada Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
TABLE 50 Canada Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
TABLE 51 Mexico Renal Denervation Market, 2018 - 2021, USD Thousands
TABLE 52 Mexico Renal Denervation Market, 2022 - 2028, USD Thousands
TABLE 53 Mexico Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
TABLE 54 Mexico Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
TABLE 55 Mexico Renal Denervation Market by End User, 2018 - 2021, USD Thousands
TABLE 56 Mexico Renal Denervation Market by End User, 2022 - 2028, USD Thousands
TABLE 57 Mexico Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
TABLE 58 Mexico Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
TABLE 59 Rest of North America Renal Denervation Market, 2018 - 2021, USD Thousands
TABLE 60 Rest of North America Renal Denervation Market, 2022 - 2028, USD Thousands
TABLE 61 Rest of North America Renal Denervation Market by Technology, 2018 - 2021, USD Thousands
TABLE 62 Rest of North America Renal Denervation Market by Technology, 2022 - 2028, USD Thousands
TABLE 63 Rest of North America Renal Denervation Market by End User, 2018 - 2021, USD Thousands
TABLE 64 Rest of North America Renal Denervation Market by End User, 2022 - 2028, USD Thousands
TABLE 65 Rest of North America Renal Denervation Market by Product Type, 2018 - 2021, USD Thousands
TABLE 66 Rest of North America Renal Denervation Market by Product Type, 2022 - 2028, USD Thousands
TABLE 67 Key Information – Abbott Laboratories
TABLE 68 key Information – Boston Scientific Corporation
TABLE 69 Key Information – Medtronic PLC
TABLE 70 Key Information – Ablative Solutions, Inc.
TABLE 71 Key Information – Mercator MedSystems, Inc.
TABLE 72 Key Information – ReCor Medical, Inc
TABLE 73 Key Information – Renal Dynamics Limited
TABLE 74 Key information – Johnson & Johnson
TABLE 75 Key Information – Terumo Corporation
List of Figures
FIG 1 Methodology for the research